Home・Akcijų sąrašas・Pacira Pharmaceuticals Inc-DE

Pacira Pharmaceuticals Inc-DE

Uždarymo kaina

SektoriusSveikatos priežiūra

27.59 3.41

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

26.19

Max

27.59

Pagrindiniai rodikliai
By Trading Economics
Pajamos	1.3M 2.9M
Pardavimai	-19M 177M
P/E Sektoriaus vid.	207.077 68.51
Pelnas, tenkantis vienai akcijai	0.6
Pelno marža	1.644
Darbuotojai	825
EBITDA	5M 30M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+17.64% upside

Dividendai
By Acuity
Kitas uždarbis	2026-11-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-40M 1.1B
Ankstesnė atidarymo kaina	24.18
Ankstesnė uždarymo kaina	27.59

Naujienos nuotaikos

By Acuity

50%

175 / 340 reitingas Healthcare

Pacira Pharmaceuticals Inc-DE Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-04 19:53; UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

2026-08-03 20:06; UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

2026-07-31 20:02; UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

2026-07-30 17:16; UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

2026-07-29 20:04; UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

2026-07-28 19:56; UTC

Event

News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

2026-07-27 18:51; UTC

Event

News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

2026-07-24 17:16; UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

2026-07-22 18:06; UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

2026-07-21 19:56; UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

2026-07-20 19:46; UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Akcijų palyginimas

Kainos pokytis

Pacira Pharmaceuticals Inc-DE Prognozė

Kainos tikslas

By TipRanks

17.64% į viršų

12 mėnesių prognozė

Vidutinis 31.67 USD 17.64%

Aukščiausias 38 USD

Žemiausias 25 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pacira Pharmaceuticals Inc-DE kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Pacira Pharmaceuticals Inc-DE akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

175 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.